These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 10722669)

  • 1. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
    Ward JL; Sherali A; Mo ZP; Tse CM
    J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
    Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
    Endres CJ; Sengupta DJ; Unadkat JD
    Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes.
    Mani RS; Hammond JR; Marjan JM; Graham KA; Young JD; Baldwin SA; Cass CE
    J Biol Chem; 1998 Nov; 273(46):30818-25. PubMed ID: 9804860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
    Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine.
    SenGupta DJ; Lum PY; Lai Y; Shubochkina E; Bakken AH; Schneider G; Unadkat JD
    Biochemistry; 2002 Feb; 41(5):1512-9. PubMed ID: 11814344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
    Visser F; Vickers MF; Ng AM; Baldwin SA; Young JD; Cass CE
    J Biol Chem; 2002 Jan; 277(1):395-401. PubMed ID: 11689555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation.
    Yao SY; Ng AM; Vickers MF; Sundaram M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2002 Jul; 277(28):24938-48. PubMed ID: 12006583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
    Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
    Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.
    Stolk M; Cooper E; Vilk G; Litchfield DW; Hammond JR
    Biochem J; 2005 Mar; 386(Pt 2):281-9. PubMed ID: 15500446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).
    Vickers MF; Mani RS; Sundaram M; Hogue DL; Young JD; Baldwin SA; Cass CE
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):21-32. PubMed ID: 10085223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
    Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
    Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
    Visser F; Zhang J; Raborn RT; Baldwin SA; Young JD; Cass CE
    Mol Pharmacol; 2005 Apr; 67(4):1291-8. PubMed ID: 15644498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
    Bone DB; Hammond JR
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae.
    Vickers MF; Kumar R; Visser F; Zhang J; Charania J; Raborn RT; Baldwin SA; Young JD; Cass CE
    Biochem Cell Biol; 2002; 80(5):639-44. PubMed ID: 12440703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole.
    Endres CJ; Unadkat JD
    Mol Pharmacol; 2005 Mar; 67(3):837-44. PubMed ID: 15557207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.
    Jennings LL; Hao C; Cabrita MA; Vickers MF; Baldwin SA; Young JD; Cass CE
    Neuropharmacology; 2001 Apr; 40(5):722-31. PubMed ID: 11311901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.